CD19 and CD70 Dual-Target Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Relapsed and Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma-Reference-Cited by-同舟云学术

CD19 and CD70 Dual-Target Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Relapsed and Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma

Published:2019-12-04 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Tu Sanfang,Zhou Xuan,Guo Zhenling,Huang Rui,Yue Chunyan,He Yanjie,Li Meifang,Chen Yiran,Liu YuChen,Chang Lung-ji,Li Yuhua

Funder

Guangdong Science and Technology Department

Natural Science Foundation of Guangdong Province

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference34 articles.

1. Primary diffuse large B-cell lymphoma of the CNS;Kluin,2008

2. Primary central nervous system lymphoma;Low;Ther Adv Neurol Disord.,2018

3. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology;Hoang-Xuan;Lancet Oncol.,2015

4. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma;Schuster;N Engl J Med.,2019

5. Chimeric antigen receptor therapy;June;N Engl J Med.,2018

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How can we improve the successful identification of patients suitable for CAR-T cell therapy?;Expert Review of Molecular Diagnostics;2024-09-11

2. Mapping the cancer surface proteome in search of target antigens for immunotherapy;Molecular Therapy;2024-09

3. Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Annals of Oncology;2024-06

4. Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up;HemaSphere;2024-06

5. The notable outcomes of modified thiotepa-based conditioning followed by autologous stem cell transplantation in primary central nervous system lymphomas: A real-life pilot study;2024-05-31